title: Repeated creatine kinase elevation under treatment with quetiapine, clozapine, and aripiprazole in an adolescent.
authors.forename: Christian J
authors.initials: CJ
authors.lastname: Bachmann
authors.forename: Britta
authors.initials: B
authors.lastname: Nicksch
authors.forename: Daleen
authors.initials: D
authors.lastname: de Lange
authors.forename: Frank M
authors.initials: FM
authors.lastname: Theisen
authors.forename: Helmut
authors.initials: H
authors.lastname: Remschmidt
mesh_terms: D000293:Adolescent; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use; D000068180:Aripiprazole; D002648:Child; D003024:Clozapine / Q000009:adverse effects* / Q000627:therapeutic use; D003402:Creatine Kinase / Q000097:blood*; D003987:Dibenzothiazepines / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D010554:Personality Disorders / Q000097:blood / Q000188:drug therapy; D010879:Piperazines / Q000009:adverse effects* / Q000627:therapeutic use; D000069348:Quetiapine Fumarate; D015363:Quinolones / Q000009:adverse effects* / Q000627:therapeutic use; D012563:Schizophrenia, Paranoid / Q000097:blood / Q000188:drug therapy; D016896:Treatment Outcome
chemical_list: D014150:Antipsychotic Agents; D003987:Dibenzothiazepines; D010879:Piperazines; D015363:Quinolones; D000069348:Quetiapine Fumarate; D000068180:Aripiprazole; D003402:Creatine Kinase; D003024:Clozapine